Background Interferon‐alpha (IFN‐α) therapy is used to treat hepatitis C infection. The
exacerbation and occurrence of psoriasis in hepatitis C patients treated with IFN‐α is …

The increase in incidence of T. tonsurans tinea capitis in the UK's inner cities resembles the
epidemic which occurred in North America in the 1970s. T. tonsurans has remained the most …

Background Multiple studies have noted an association between hepatitis C and psoriasis,
but it is not known whether psoriasis is a result of treatment modalities for hepatitis C or a …

BACKGROUND: Treating psoriasis in patients with concomitant hepatitis C virus (HCV)
infection presents a special challenge. Not only is psoriasis exacerbated by interferon …

Tumor necrosis factor-alpha (TNF-α) inhibitors represent an effective treatment for severe
psoriasis in hepatitis C virus (HCV) patients. The literature reports mainly on short-term …

Psoriasis is an inflammatory skin disease of unknown etiology. Many observations indicate
that T cells play an important role in the pathogenesis of the disease. Infections have been …

Hepatitis C virus (HCV) is a bloodborne agent transmitted by apparent and inapparent
parenteral procedures representing a frequent cause of liver disease world‐wide. Both …

A 45-year-old woman with chronic hepatitis C was treated with peginterferon alpha-2b in
combination with ribavirin, which activated psoriasis. In the patient, psoriasis reoccurred …

Exacerbation of preexisting and development of new‐onset psoriasis have been reported
secondary to interferon treatment and, more recently, with newer biologic agents. We report …

Psoriasis is a chronic inflammatory skin disease associated with various complications such
as arthritis, diabetes mellitus and hypertension. Hepatitis C is caused by chronic infection of …